| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors
|
Gupta, Vikas
|
|
|
120 |
7 |
p. 1367-1379
|
artikel
|
| 2 |
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience
|
Rothe, Achim
|
|
|
120 |
7 |
p. 1470-1472
|
artikel
|
| 3 |
CCR1 blockade and myeloma bone disease
|
Sebag, Michael
|
|
|
120 |
7 |
p. 1351-1352
|
artikel
|
| 4 |
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
|
Dairaghi, Daniel J.
|
|
|
120 |
7 |
p. 1449-1457
|
artikel
|
| 5 |
Circulating microparticles do not all share biophysical light scatter properties with immune complexes when analyzed by flow cytometry
|
Hexley, Philip
|
|
|
120 |
7 |
p. 1528-1529
|
artikel
|
| 6 |
Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates
|
Pandrea, Ivona
|
|
|
120 |
7 |
p. 1357-1366
|
artikel
|
| 7 |
Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML
|
Lo, Miao-Chia
|
|
|
120 |
7 |
p. 1473-1484
|
artikel
|
| 8 |
Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells
|
Everts, Bart
|
|
|
120 |
7 |
p. 1422-1431
|
artikel
|
| 9 |
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
|
Campbell, Peter J.
|
|
|
120 |
7 |
p. 1409-1411
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
120 |
7 |
p. i
|
artikel
|
| 11 |
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS
|
Deeg, H. Joachim
|
|
|
120 |
7 |
p. 1398-1408
|
artikel
|
| 12 |
Has Ly6G finally found a job?
|
Hickey, Michael J.
|
|
|
120 |
7 |
p. 1352-1353
|
artikel
|
| 13 |
HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes
|
Wong, Gladys W.
|
|
|
120 |
7 |
p. 1439-1448
|
artikel
|
| 14 |
How I treat newly diagnosed chronic phase CML
|
Cortes, Jorge
|
|
|
120 |
7 |
p. 1390-1397
|
artikel
|
| 15 |
Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study
|
Holzhauer, Susanne
|
|
|
120 |
7 |
p. 1510-1515
|
artikel
|
| 16 |
Leaky gut, clotting, and vasculopathy in SIV
|
Hunt, Peter W.
|
|
|
120 |
7 |
p. 1350-1351
|
artikel
|
| 17 |
Linger RMA, DeRyckere D, Brandão L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood. 2009;114(13):2678–2687.
|
|
|
|
120 |
7 |
p. 1533
|
artikel
|
| 18 |
Ly6G ligation blocks recruitment of neutrophils via a β2-integrin–dependent mechanism
|
Wang, Jun-Xia
|
|
|
120 |
7 |
p. 1489-1498
|
artikel
|
| 19 |
Meningeal myelomatosis
|
Anwer, Saiyed
|
|
|
120 |
7 |
p. 1356
|
artikel
|
| 20 |
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
|
Ramsay, Alan G.
|
|
|
120 |
7 |
p. 1412-1421
|
artikel
|
| 21 |
NFAT control of innate immunity
|
Fric, Jan
|
|
|
120 |
7 |
p. 1380-1389
|
artikel
|
| 22 |
Notch and PI3K: how is the road traveled?
|
Bailis, Will
|
|
|
120 |
7 |
p. 1349-1350
|
artikel
|
| 23 |
Pericytes promote selective vessel regression to regulate vascular patterning
|
Simonavicius, Nicole
|
|
|
120 |
7 |
p. 1516-1527
|
artikel
|
| 24 |
Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia
|
Kiyomizu, Kazunobu
|
|
|
120 |
7 |
p. 1499-1509
|
artikel
|
| 25 |
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
|
Lemonnier, François
|
|
|
120 |
7 |
p. 1466-1469
|
artikel
|
| 26 |
Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2–positive chronic eosinophilic leukemia
|
Lierman, Els
|
|
|
120 |
7 |
p. 1529-1531
|
artikel
|
| 27 |
Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia
|
Doisaki, Sayoko
|
|
|
120 |
7 |
p. 1485-1488
|
artikel
|
| 28 |
S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma
|
Liu, Yong
|
|
|
120 |
7 |
p. 1458-1465
|
artikel
|
| 29 |
The race for the prize: T-cell trafficking strategies for optimal surveillance
|
Lee, Minyi
|
|
|
120 |
7 |
p. 1432-1438
|
artikel
|
| 30 |
Thrombophilia screening: whom to test?
|
Bruce, Aisha
|
|
|
120 |
7 |
p. 1353-1355
|
artikel
|
| 31 |
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension
|
Anthi, Anastasia
|
|
|
120 |
7 |
p. 1531-1532
|
artikel
|
Tijdschrift beschrijving